downstream and that aspartic acid is not a limiting factor for the pathway.
Following the first branch point separating lysine biosynthesis from that of methionine, threonine and isoleucine, homoserine is converted to Ophosphohomoserine (OPH) by homoserine kinase (EC 2.7.1.39). OPH marks the second branch point in the pathway that divides methionine biosynthesis from that of threonine and isoleucine. Threonine synthase (TS; EC 4.2.99.2) and cystathionine g-synthase (CGS; EC 2.5.1.48, formerly assigned as EC 4.2.99.9) both catalyse a nucleophilic attack on OPH. In the case of TS, a water molecule is used as the nucleophile resulting in threonine formation. On the other hand, CGS uses cysteine as the nucleophile to form cystathionine and marks both the entry of a sulfur atom into the pathway, and the first committed step of methionine biosynthesis.
Biochemical analyses of TS from several plant species have shown that it is not feedback-regulated by threonine or isoleucine, however, its activity did appear to be influenced by the methionine pathway. SAM, the direct metabolite of methionine, markedly stimulated the activity of plant TS enzymes in a reversible and cooperative manner (Madison and Thompson 1976; Aarnes 1978; Giovanelli et al. 1984 ). This regulation is unique to higher plants, as the bacterial enzyme is not stimulated in this manner (Curien et al. 1996) .
Steps unique to methionine biosynthesis
The condensation of OPH and cysteine by CGS to form cystathionine represents the first step in the pathway that is unique to methionine biosynthesis. As such, it is expected that this step is important for regulating methionine accumulation (Ravanel et al. 1998b) . Markedly reduced levels of extractable CGS activity were observed in both Lemna (Thompson et al. 1982b) and barley (Rognes et al. 1986 ) plants when grown in the presence of exogenous methionine, suggesting that methionine or one of its metabolites negatively regulates the amount of active CGS. However, activity of the CGS enzyme was not inhibited by methionine or SAM in vitro, indicating that CGS is not an allosteric enzyme (Thompson et al. 1982a) , and therefore the mechanism of this regulation was not known. Treatment of barley plants with lysine and threonine, which inhibits the aspartic acid metabolic pathway and thus reduces methionine levels, also resulted in an almost four-fold increase in the levels of extractable CGS activity (Rognes et al. 1986) .
Following the CGS reaction, methionine is synthesised in two additional steps that are catalysed by cystathionine b-lyase (EC 4.4.1.8; cystathionine →homocysteine) and methionine synthase (EC 2.1.1.14), respectively. Methionine synthase catalyses incorporation of a methyl group from methyltetrahydrofolate into homocysteine to form methionine. Methionine is either directly incorporated into protein or metabolised into SAM. The synthesis of SAM from methionine is catalysed by SAM synthetase (SAMS; EC 2.5.1.6) and the activity of this enzyme has been shown to be inhibited by SAM in pea seedlings (Aarnes 1977) . The Arabidopsis genome contains at least three, and possibly four, genes for SAMS (Peleman et al. 1989b; Shen et al. 2002) . Expression of SAMS1 and SAMS2 genes were compared with enzyme activity that indicated developmental regulation of these two genes occurs primarily at the mRNA level (Peleman et al. 1989a ).
Recycling of methionine
SAM is used in a wide variety of biological reactions and represents a major pathway of methionine metabolism. The flux through methionine was analysed in Lemna and it was determined that over 80% of methionine is metabolised into SAM, of which approximately 90% is used for transmethylation reactions (Giovanelli et al. 1985) . The product of these methylation reactions in higher plants is S-adenosylhomocysteine. SAdenosylhomocysteine is recycled to homocysteine by adenosylhomocysteinase (EC 3.3.1.1), prior to the reincorporation of a methyl group by methionine synthase and regeneration of the methionine molecule (methionine cycle). Methionine synthase therefore represents both the last reaction of methionine biosynthesis and of methionine recycling following methylation reactions. SAM also serves as a precursor for biosynthesis of ethylene and polyamines. The secondary product of these pathways is 5Ј-methylthioadenosine, which is directly recycled back to methionine in four enzyme-catalysed reactions that conserves the sulfur and methyl group (5Ј-methylthioadenosine cycle). Despite the large flux of methionine through SAM, there is no net loss of methionine due to recycling, and thus protein synthesis is the only major reaction that consumes an entire methionine molecule.
An additional metabolic pathway involving the recycling of methionine has been shown to exist in higher plants and is referred to as the Smethylmethionine (SMM) cycle (Mudd and Datko 1990) . SAM:methionine S-methyltransferase (EC 2.1.1.12) catalyses the formation of SMM from methionine in a reaction utilising SAM as a methyl donor (Giovanelli et al. 1980; Mudd and Datko 1990; James et al. 1995 ). Two methionine molecules are then regenerated from SMM by transfer of a methyl group from SMM to homocysteine. This second reaction is catalysed by homocysteine S-methytransferase (EC 2.1.1.10) (Giovanelli et al. 1980; Ranocha et al. 2000) . SMM was identified as a major component in the phloem of several higher plant species (Bourgis et al. 1999) , suggesting that it has a role in the transport of methionine in plant tissues. The first reaction of the SMM cycle may therefore serve to convert methionine into a more transportable form, where it is then reconverted back to methionine in the sink tissues. A model has been proposed where the SMM cycle was suggested to also have a major role in the homeostasis of SAM levels in higher plants (Ranocha et al. 2001) .
Regulating metabolic flux to methionine in the pathway As described above, early pioneering work identified many of the steps involved in the aspartic acid metabolic pathway. These studies had a strong biochemical basis and revealed much information about the enzymes involved and their activities. However, the regulatory mechanisms and in vivo dynamics of the methionine biosynthetic pathway remained unknown. Levels of the CGS enzyme, as opposed to enzymatic activity, were known to respond to changes in methionine availability, although the mechanism by which this occurred was unclear. Moreover, TS activity appeared to be influenced by the methionine metabolic product SAM, yet it was unknown whether the in vivo interactions between the threonine and methionine branch points had any influence on the regulation of methionine accumulation.
Significant advances in our understanding on the regulation of the methionine biosynthetic pathway in plants were provided through the isolation and characterisation of genetic mutants in which methionine accumulation is altered Chiba et al. 1999; Bartlem et al. 2000; Goto et al. 2002; Shen et al. 2002; Onouchi et al. 2005) , as described in further detail below.
Genetic approaches using Arabidopsis
Ethionine is a toxic analogue of methionine (Alix 1982 ) that has been used to isolate methionine over-accumulating mutants of bacteria (Kappy and Metzenberg 1965) and yeast (Sorsoli et al. 1964; Mertz and Spence 1972) . The phenotype of ethionineresistance has also been used to successfully identify plant cell lines of tobacco, soybean, carrot and alfalfa that over-accumulate soluble methionine (Widholm 1976; Reish et al. 1981; Gonzales et al. 1984; Greenberg et al. 1988) .
In recent times, Arabidopsis has been adopted as a genetic tool to further elucidate the regulation and in vivo dynamics of the methionine biosynthetic pathway in higher plants. The general approach has been to subject wild-type seeds to a mutagenesis treatment, and screen for mutants displaying a phenotype of methionine overaccumulation. This screening involves the germination of mutant seeds on sterile media containing a toxic concentration of ethionine. Toxicity of ethionine is explained as that it is used in many of the cellular reactions, including protein synthesis and SAM synthesis, in place of methionine. Mutant plants that over-accumulate soluble methionine are able to overcome the toxic levels of ethionine and survive, whereas wild-type plants die soon after germination ( Figure 2 ). Once confirmed to contain elevated levels of soluble methionine, the mutant plants are referred to with the nomenclature mto (for methionine overaccumulation) mutants.
Soluble methionine levels in wild-type plants are generally low and require sensitive high performance liquid chromatography analysis. As a result, a screen for mutants with reduced methionine accumulation has yet to be developed, although severe growth defects following specific inhibition of the biosynthetic pathway suggest they may not survive (Datko and Mudd 1982; Thompson et al. 1982b) .
To date, three mto loci have been identified that affect different steps of the biosynthetic pathway and have provided important insight into regulation of methionine accumulation in whole plants. The mto1 , mto2 (Bartlem et al. 2000) and mto3 (Goto et al. 2002; Shen et al. 2002) mutants contain lesions in genes encoding CGS, TS and SAMS, respectively.
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CGS enzyme is feedback regulated at the level of mRNA stability: mto1 mutant
The first Arabidopsis methionine over-accumulating mutant to be isolated was mto1-1 . As suggested by its ethionine-resistant phenotype, soluble methionine levels in young mto1-1 plants accumulated up to 40-fold higher than that in wild type. Surprisingly, accumulation of other aspartic acid family amino acids were not affected, demonstrating that the aspartic acid metabolic pathway is able to compensate for the increased metabolic flux to methionine without limiting the other branches of the pathway.
Genetic mapping and sequencing identified the causative mutation as a single base-pair change within the exon 1 coding region of the CGS gene (Chiba et al. 1999) . Although the exon 1 amino acid sequence is generally poorly conserved, the mto1 mutation resides within a 40-residue region that is highly conserved among plant species. All subsequent mto1 alleles were also found to be located within this region. Alaninesubstitution experiments identified a short stretch of amino acid sequence, Arg-Arg-Asn-Cys-Ser-Asn-IleGly-Val-Ala-Gln, that covers the mto1 mutation sites that is important for the regulation, which is now referred to as the MTO1 region (Ominato et al. 2002) (Figure 3) . As a result of the mutation within the CGS exon 1 coding sequence, CGS mRNA levels were two-to four-fold higher in mto1 than in wild-type plants, which is reflected by elevated levels of CGS protein and enzyme activity (Chiba et al. 1999; Ominato et al. 2002) . Analysis of the regulation defect in mto1 revealed that wild-type CGS is negatively regulated in response to exogenous application of methionine, and that posttranscriptional regulation at the level of mRNA stability plays a major role (Chiba et al. 1999 ). Additional studies have subsequently shown that the effector of this feedback regulation is not methionine itself, but rather its direct metabolite, SAM .
The above work provided a mechanistic explanation for earlier findings that levels of extractable CGS were reduced by methionine treatment (Thompson et al. 1982b; Rognes et al. 1986 ). Moreover, it contributed to our understanding of the dynamics of the aspartic acid metabolic pathway by providing in vivo evidence that regulation of CGS levels is required for the strict control of methionine biosynthesis, and that compensatory mechanisms exist to adjust for changes in methionine accumulation and ensure that levels of other amino acids in the common pathway remain constant.
In addition to demonstrating the role of CGS regulation in controlling methionine accumulation, analysis of the mto1 mutants has also led to the discovery of a novel feedback regulatory mechanism in plants (Onouchi et al. 2005) . Although increased SAM levels result in CGS mRNA degradation, the nascent exon 1 peptide sequence is also required for this regulation, and thus translation of the mRNA must first be initiated Lambein et al. 2003) . It has recently been shown that SAM actually first induces a temporal arrest in translation elongation immediately downstream of the MTO1 region, suggesting that the MTO1 region acts within the ribosomal exit tunnel, and that this translation arrest triggers degradation of its own mRNA (Onouchi et al. 2005) (Figure 4 ).
Threonine biosynthesis regulates metabolic flux to methionine: mto2 mutant
Despite the findings that expression of the CGS gene is (2002) with permission from the Genetic Society of Japan. Figure 3 . mto1 mutation sites and the MTO1 region. mto1 mutation sites are indicated above the amino acid sequence alignment of CGS from seven plant species for the highly conserved region. Identical amino acid residues are reversed and similar ones are shaded. The MTO1 region marked below the alignment was identified by alaninesubstitution experiments (Ominato et al. 2002) . Filled arrowhead indicates the position of translation arrest induced by SAM. Genbank/EMBL/DDBJ accession numbers are; Arabidopsis, AF039206; strawberry (Fragaria vesca), FVAJ1451; soybean (Glycine max), AF141602, BG363230, and 10 other ESTs; ice plant (Mesembryanthemum crystallinum), AF069317; tobacco (Nicotiana tabacum), AF097180, AB035300; potato (Solanum tuberosum), AF144102; maize (Zea mays), AF007785.
feedback-regulated, several reports indicated that regulation of the CGS gene alone is not sufficient to regulate methionine biosynthesis in higher plants and that other mechanisms are also involved (Thompson et al. 1982b (Thompson et al. , 1982a Ravanel et al. 1998b ). Based on determined K m values and estimated subcellular concentration of its substrates in Arabidopsis, it has been proposed that the CGS reaction normally proceeds at approximately 1-2% of its maximal rate, and therefore, CGS is not the rate-limiting step in methionine biosynthesis (Ravanel et al. 1998a) . Inhibitor studies of CGS in Lemna also revealed that only 16% of CGS control activity is necessary for normal rates of methionine biosynthesis and plant growth, and also that down-regulation of CGS to 15% of control activity is not sufficient to reduce the rate of methionine biosynthesis (Thompson et al. 1982b) .
The methionine biosynthetic pathway in bacteria does not branch at OPH, but rather at an earlier step where homoserine is first converted to O-succinylhomoserine by homoserine O-transsuccinylase (EC 2.3.1.46), prior to a CGS-catalysed reaction resulting in cystathionine formation (Chattopadhyay et al. 1991) (Figure 1) . The competition between TS and CGS for the common OPH substrate is therefore unique to higher plants. Studies in tobacco and soybean cell lines had suggested that OPH is preferentially drawn into threonine biosynthesis and that depression of TS allows increased methionine biosynthesis (Greenberg et al. 1988; Muhitch 1997) . In addition, TS activity was shown to be stimulated by SAM in vitro (Madison and Thompson 1976; Aarnes 1978; Giovanelli et al. 1984) . Although these studies indicated that the competition between TS and CGS may have a role in regulating methionine biosynthesis, no experimental evidence for this was available and the hypothesis assumed OPH availability was limited. Simple competition also did not explain the fact that threonine was not severely reduced in the mto1 methionine over-accumulating mutant .
The Arabidopsis mto2-1 mutant was isolated in an independent screen from that of mto1, and overaccumulated soluble methionine in young rosettes to approximately 20-fold higher than that in wild type. Unlike that observed for mto1, soluble threonine levels were markedly reduced in young mto2-1 rosettes to 6% of that in wild type, whereas accumulation of lysine and isoleucine was unaffected (Bartlem et al. 2000) . The amino acid accumulation profile of mto2-1 indicated that the branch point in the methionine biosynthetic pathway between methionine and threonine was affected. As threonine levels were normal in mto1 mutants, it was unlikely that the defect in mto2-1 caused increased activity of methionine-specific steps. A defect in SAM biosynthesis could explain the mto2-1 phenotype, which would result in reduced activation of TS enzyme. However, SAM accumulation was three-fold higher in young mto2-1 rosettes, suggesting this was not the case.
A single base-pair mutation within the gene encoding TS that altered the amino acid sequence of the enzyme active site was identified as the causative lesion in mto2-1 (Bartlem et al. 2000) . Moreover, the mutation was shown to reduce TS activity by functional complementation of an E. coli thrC auxotrophic mutant (Bartlem et al. 2000) (Figure 5A ). Methionine overaccumulation in mto2-1 was therefore the direct result of reduced threonine biosynthesis, revealing that TS and CGS do indeed compete for a limited substrate in vivo (Bartlem et al. 2000; Lee et al. 2005) . Interestingly, although TS mRNA and protein levels were normal in mto2-1, accumulation of CGS mRNA and protein were negatively correlated with that of methionine and reduced to approximately 40% of that in wild type (Bartlem et al. 2000) (Figure 5B ). The reduced levels of CGS associated with methionine over-accumulation showed that the regulatory mechanism controlling CGS mRNA accumulation in response to increased SAM (Chiba et al. 1999; Chiba et al. 2003 ) was functioning normally. Methionine was able to over-accumulate 20-fold in mto2-1 when CGS levels were markedly reduced. This fact provides a clear in vivo demonstration that TS This translation arrest triggers CGS mRNA degradation (Onouchi et al. 2005) . A 5Ј-truncated RNA species are formed as degradation intermediate (Chiba et al. 1999; Chiba et al. 2003) activity has a key role in regulating the carbon flow into the methionine biosynthetic pathway and, when TS activity is compromised, the regulation of CGS alone is not sufficient. This is in agreement with the finding that antisense repression of the TS gene in transgenic potato resulted in a reduction of TS activity to 6% of wild type and up to 230-fold increase in soluble methionine in leaf and tuber tissues, respectively (Zeh et al. 2001) .
The mto2-1 mutation also revealed another interesting aspect of the dynamics of aspartic acid metabolism: similar concentrations of isoleucine in mto2-1 and wild type indicated that even when soluble threonine is reduced to 6% of that in wild type, this is sufficient to support isoleucine biosynthesis, and that threonine may even be preferentially drawn into isoleucine biosynthesis to fulfil this demand prior to being utilized for protein synthesis.
Conversion of methionine to SAM is required for biosynthetic regulation: mto3 mutant
Two alleles of the mto3 mutation have been isolated in independent studies and both carry single base-pair changes within the coding region for the active site of the SAMS3 enzyme. The mto3-1 mutation alters the ATP binding site within the active site (Shen et al. 2002) , whereas mto3-2 changes the Asp-167 residue that likely binds the methionine substrate (Goto et al. 2002) (Figure  6 ). Although both mto3-1 and mto3-2 affect the SAMS3 active site, the severity of the phenotypes were different in the two mutations. In young mto3-1 plants, concentrations of methionine were 244-fold higher than that in wild type and SAM levels were reduced by 35% (Shen et al. 2002) . On the other hand, methionine concentrations were 20-fold higher in young plants of the weaker mto3-2 allele (Goto et al. 2002) and SAM levels were not detectably different (D. Goto, M. Ogi, S. Naito, unpublished data) (Table 1) .
Intriguingly, there was not a linear relationship between the increases in methionine accumulation observed in mto3 mutants and decrease in SAM, particularly in the case of mto3-2. This may be due to the influence of recycling pathways or compartmentalisation of SAM pools within individual cells (see below). As mentioned above, Arabidopsis contains at least three SAMS genes, and possibly a fourth (Shen et al. 2002) . The fact that these other genes do not complement the mto3 mutations demonstrates that there is little redundancy and that the individual SAMS genes have likely evolved distinct functions in methionine metabolism. Moreover, the two mutants were isolated in the SAMS3 gene, and not in other SAMS genes, further suggesting that functional SAMS3 enzyme is specifically required for regulation of methionine accumulation. Mutations in SAMS3 prevent flow of excess methionine into the metabolic pathway, however, they still allow normal flux to methionine at the OPH branch point. Combined with the finding that CGS levels at least in mto3-2 are not appreciably affected, despite the 20-fold increase in methionine (Goto et al. 2002) , this also suggested that SAM and not methionine is likely to be the effector of CGS regulation, which was later established by in vitro experiments .
mto1, mto2 and mto3 represent three important genetic loci affecting different steps of the methionine biosynthetic pathway. Although they all over-accumulate soluble methionine, they each have distinct amino acid profiles. In mto1, methionine and SAM concentrations are increased, whereas threonine levels are normal. In contrast, increased methionine and SAM in mto2 is associated with a severe reduction in threonine accumulation. mto3 mutants have a more specific profile in that they only accumulate methionine, and SAM levels are either slightly reduced or not appreciably affected (Table 1) .
Remaining questions about the dynamics of methionine biosynthesis
In order to fully understand the regulation of metabolic pathways in plants, it is important to remember that they are present within a multicellular, eukaryotic environment. As such, they are subject to temporal and spatial developmental regulation, in addition to possible compartmentalisation within individual cells. The methionine over-accumulating mutants have provided a greater understanding on the dynamics of carbon flux through the methionine biosynthetic pathway, however, they have also raised several new questions.
Does CGS also have a role in methionine metabolism?
The mto1 mutant alleles all reside within a highly conserved region of the CGS exon 1 polypeptide that is involved in the feedback regulation of CGS mRNA stability by SAM. Unlike that observed in Lemna and Arabidopsis, analysis of antisense TS suppression lines in potato suggested that they lack the feedback regulation mechanism and rely primarily on TS activity for control of the methionine biosynthetic pathway (Zeh et al. 2001 ). This was surprising as the MTO1 region has also been conserved in the potato CGS gene (Figure 3) , indicating it may also serve another function.
Additional studies in tobacco have raised the interesting possibility that the N-terminal region of CGS may be involved in more than just regulating CGS mRNA stability, but may also control methionine accumulation by somehow regulating the methionine metabolic pathway . As expected, over-expression of wild-type Arabidopsis CGS in transgenic tobacco resulted in increased methionine accumulation. In contrast, over-expression of a CGS construct lacking the MTO1 region resulted in not only increased methionine but also high levels of ethylene and methionine catabolic products .
Complexity introduced by compartmentalisation
The majority of the aspartic acid metabolic pathway occurs within the chloroplasts of plant cells (Wallsgrove et al. 1983; Ravanel et al. 1998b) , although the final steps of methionine biosynthesis are unique in that chloroplasts only contain approximately 70% of the cystathionine b-lyase activity and essentially no methionine synthase activity (Wallsgrove et al. 1983 ). SAMS activity is thought to be present in the cytoplasm (Wallsgrove et al. 1983; Peleman et al. 1989b ). The separation of SAM synthesis from that of CGS activity explains the requirement for a complex mechanism in which SAM induces the degradation of CGS mRNA during translation in the cytoplasm prior to transport of the protein to the chloroplast. This also highlights the strong possibility of additional physical separation of regulatory components within the biosynthetic pathway. For example, it is interesting to know why no reduction in SAM was seen in mto3-2, although the increase in methionine was assumed to be due to decreased metabolism of methionine into SAM.
It has recently been shown that one of the methionine synthase isoforms in Arabidopsis is localised to the 18.
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chloroplast, suggesting that chloroplasts are autonomous for de novo methionine biosynthesis and that the other two isoforms in the cytoplasm are more likely to be involved in methionine synthesis through recycling pathways (Ravanel et al. 2004 ). Moreover, it was also found that SAM is transported into the chloroplasts in a carrier-mediated process, raising the possibility of different subcellular concentrations (Ravanel et al. 2004) . It is tempting to speculate that similar functional differences exist for the SAMS enzymes. Although evidence is lacking, one possible explanation for the lack of correlation between decrease of SAM and increase of methionine in mto3 mutants is that the recycling pathway is specifically disrupted, introducing a rate-limiting step on the cycling of methionine to SAM. Under this model, de novo synthesis of methionine and SAM would not be affected and may even be regulated to maintain required concentrations of SAM. Isolation of mutants in the other SAMS genes, their phenotypic comparisons and doublemutant analysis is likely to provide further insight into the functional differences.
The methionine biosynthetic pathway is subject to additional developmental regulation
The over-accumulation of methionine has been found to vary significantly in the mto mutants depending on the age of the plants and the tissue examined. In mto1 mutants, methionine levels are up to 40-fold higher than wild type in leaves of young plants, however, this overaccumulation decreases after 25 days and by 40 days the methionine level is similar to that in wild type Bartlem et al. 2000; Goto et al. 2002) . In the mto2 mutant, threonine levels also increased from 6% of wild type in young leaves, up to 85% of wild type levels in 30-day-old plants (Bartlem et al. 2000) (Figure 7 ). In fact, mto2 seedlings require threonine supplementation for normal growth when plated on synthetic agar medium. Despite the differences in their relative concentrations at specific stages, temporal patterns of threonine levels were similar between wild type and mto2 in that several-fold increases were seen after 20 days of growth. In wild-type rosettes, this increase occurred without a reduction in soluble methionine concentration. It is interesting that the changes in methionine and threonine in both wild type and mto2 occur as the plants enter the reproductive growth stage.
In older plants (40 days old), the concentration of soluble threonine was reduced in all tissues of mto2 compared to that in wild type (Bartlem et al. 2000) (Figure 7 ). On the other hand, soluble methionine concentrations were similar to that in wild type, in contrast to that in young plants. This suggests that methionine biosynthesis may be under additional stricter control in ageing plants. The fact that reduced methionine over-accumulation was observed in all three mto mutants, which all affect different regulatory steps of the pathway, suggests that tissue-specific accumulation of methionine may be regulated through a translocation process. This is in agreement with several reports showing that excess methionine may be transported from source leaf tissue to reproductive sink tissues in older plants Naito et al. 1994; Kim et al. 2002) .
Developmental regulation of methionine in mto2 does, however, suggest that temporal reduction in methionine may not be simply due to translocation to sink tissues. Parallel increases of threonine in old leaves indicate relaxing of the competitive pressure on the OPH branch point following transition to reproductive growth (Bartlem et al. 2000) . Down-regulation of CGS was also not responsible for the reduced competitive pressure, as CGS mRNA levels remained constant. It is apparent that the aspartic acid metabolic pathway and methionine biosynthesis is subject to complex regulatory mechanisms and that the dynamics of this regulation change over the course of the plant life cycle.
Concluding remarks
The genetic studies described above and others using transgenic plants (for reviews, see also Amir et al. 2002; Hesse et al. 2004 ) have begun to provide valuable insight into the dynamics of methionine biosynthetic pathway in plants. It must be remembered that methionine biosynthesis is not a simple pathway with defined beginning and end points, but rather part of a complex metabolic pathway that involves synthesis of other amino acids and includes multiple metabolic fates and recycling events. In addition, these processes are occurring in different compartments within individual cells and are subject to complex spatial and temporal developmental regulation. It is clear that there is still much to be learnt and that this field will benefit from metabolomic analysis, continued biochemical studies and expansion of genetic studies to incorporate developmental aspects of the pathway.
